Amoureux M C, Wurch T, Pauwels P J
Laboratory of Cellular and Molecular Neurobiology, Centre de Recherche Pierre Fabre, Castres, France.
Biochem Biophys Res Commun. 1995 Sep 14;214(2):639-45. doi: 10.1006/bbrc.1995.2334.
The mRNA content of the brain-specific metallothionein-III (MT-III) protein was measured by quantitative reverse transcription-polymerase chain reaction (RT-PCR) in two transformed glial cell lines: rat C6-glial and human U-373 MG cells. Low levels of MT-III mRNA were detected compared to a high expression of this mRNA in primary cultures of rat astrocytes. C6-glial cell lines stably transfected with a human 5-HT1D alpha or 5-HT1D beta receptor gene showed a decrease (87 to 93%) in basal [3H]thymidine incorporation, whereas their MT-III mRNA content was more than 30-fold increased compared to plasmid transfected C6-glial cells. The inverse proportion between mitogenic activity and MT-III mRNA content suggests that MT-III may act as a growth inhibitory factor in rat C6-glial cells.
采用定量逆转录聚合酶链反应(RT-PCR)测定了两种转化神经胶质细胞系(大鼠C6神经胶质细胞和人U-373 MG细胞)中脑特异性金属硫蛋白III(MT-III)的mRNA含量。与大鼠星形胶质细胞原代培养物中该mRNA的高表达相比,检测到MT-III mRNA的水平较低。稳定转染人5-HT1Dα或5-HT1Dβ受体基因的C6神经胶质细胞系,其基础[3H]胸苷掺入量降低(87%至93%),而与质粒转染的C6神经胶质细胞相比,其MT-III mRNA含量增加了30倍以上。促有丝分裂活性与MT-III mRNA含量之间的反比关系表明,MT-III可能在大鼠C6神经胶质细胞中作为生长抑制因子发挥作用。